Randomized, double-blind, phase II study evaluating same-day vs next-day administration of pegfilgrastim with R-CHOP in non-Hodgkin's lymphoma patients
- A. Saven
- , L. Schwartzberg
- , P. Kaywin
- , N. Bartlett
- , L. Dean
- , S. Shahin
- , L. Dreiling
Research output: Contribution to journal › Article › peer-review